Showing results (31-40 of 146) with videos related to
Sort By:
Pageof 15
Advances in Chronic Kidney Disease|May 3, 2011
Blood purification in toxicology: nephrology's ugly ducklingMarc Ghannoum, Thomas D Nolin, Valery Lavergne, et al.Journal of General Internal Medicine|April 28, 2010
Primary care of the renal transplant patientGaurav Gupta, Mark L Unruh, Thomas D Nolin, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 4, 2014
Decreased conversion of 25-hydroxyvitamin D3 to 24,25-dihydroxyvitamin D3 following cholecalciferol therapy in patients with CKDJason R Stubbs, Shiqin Zhang, Peter A Friedman, et al.Journal of Pharmaceutical and Biomedical Analysis|May 4, 2024
Development and validation of an UPLC-MS/MS method for the simultaneous determination of fexofenadine and olmesartan in human serum: Application to in vivo pharmacokinetic studiesRaymond E West, Junmei Zhang, Melanie S Joy, et al.Seminars in Dialysis|May 15, 2014
Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practiceMarc Ghannoum, Josée Bouchard, Thomas D Nolin, et al.Nephrologie & Therapeutique|April 12, 2015
[Drug pharmacokinetics in renal failure: What's new?]Judith Naud, Christopher Dumayne, Thomas D Nolin, et al.The Lancet. Oncology|August 16, 2021
Effect of removing race from glomerular filtration rate-estimating equations on anticancer drug dosing and eligibility: a retrospective analysis of National Cancer Institute phase 1 clinical trial participantsMorgan A Casal, S Percy Ivy, Jan H Beumer, et al.Journal of Pharmaceutical and Biomedical Analysis|July 6, 2019
Development and validation of a UHPLC-MS/MS method for measurement of a gut-derived uremic toxin panel in human serum: An application in patients with kidney diseaseAlexander J Prokopienko, Raymond E West, Jason R Stubbs, et al.Journal of Clinical Pharmacology|March 5, 2022
Use of Physiologically Based Pharmacokinetic Modeling to Evaluate the Impact of Chronic Kidney Disease on CYP3A4-Mediated Metabolism of SaxagliptinMorgan A Butrovich, Weifeng Tang, David W Boulton, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2010
Multiple-dose pharmacokinetics and pharmacodynamics of N-acetylcysteine in patients with end-stage renal diseaseThomas D Nolin, Rosemary Ouseph, Jonathan Himmelfarb, et al.Pageof 15